AI in Regulatory Affairs

Enabling Successful Trial Recruitment through Centralized Technology Platforms

Clinical Trial Modernization - Technological, Operational, and Regulatory Advances

Leveraging Real World Evidence, Registries, and Decentralized Trials for Next Generation Innovation

Artificial Intelligence Meets Pharmacovigilance

EDITORIAL SECTION

STRATEGY

Strategic Positioning for M&A

The biotechnology sector is characterised by a constant influx of small highly specialised companies

RESEARCH DEVELOPMENT

Cytiva Laboratory capsule filters

Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling

CLINICAL TRIALS

Virtual Clinical Trials

Virtual digital and decentralized are all descriptions of the novel ways that using technology changes

Bio Pharma

Biosimilars and Biobetters

Biosimilars are biologic medical products that are essentially identical to an original product manufactured

MANUFACTURING

Transformative Convergence of AI in Pharmaceutical Manufacturing

The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by

Information Technology

Transformative Impact of Artificial Intelligence on Clinical Trials

Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries

EXPERT Talk

Sustainable Innovation in Biopharma: Aligning Therapeutic Progress with Environmental Responsibility

To genuinely align RD with environmental responsibility biopharma organisations must embrace systemic structural and cultural transformations

Advisory Board

Victor M. Diaz Perez

Kishore Hotha

Joab Williamson

Scott M. Wheelwright

Tamara Miller

Juris Hmelnickis

David Contorno

Svetlana Busiguina

Eiman Shafa

Nigel Cryer FRSC

Hector Alejandro Andonie

Josipa Ljubicic

KNOWLEDGE BANK

Articles

Pharma Display Advertising: Boost Leads & Webinar Registrations Instantly

With the ever growing competition in the pharmaceutical industry firms are always trying to find viable methods of accessing decisionmakers creating qualified leads and marketing thought leadership opportunities eg webinars The old ways of outreach are no longer effective in the digitalfirst environment where the executives of healthcare the researchers of pharmaceuticals and the leaders of the in...

Techno Trends

Case Western Reserve Scientists Discover Novel Molecular Target for Parkinson’s Disease

Researchers at Case Western Reserve University have discovered a new biochemical pathway that could lead to treatments targeting the underlying causes of Parkinsons disease

Projects

PharmaEssentia Invests $46M to Expand U.S. Manufacturing Footprint for BESREMi®

PharmaEssentia Corporation has announced plans to establish a new wholly owned manufacturing subsidiary in Puerto Rico The US million investment aims to expand the production of BESREMi

Research Insights

Controllable protein design via autoregressive direct coupling analysis conditioned on principal components

We present FeatureDCA a statistical framework for protein sequence modeling and generation that extends Direct Coupling Analysis DCA

White Papers

Accelerating In-Vitro Antibody Discovery with Artificial Intelligence

Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities

press releasesRead more...

ImmunoBrain to Present Topline Phase 1b Clinical Data for Immune Checkpoint Treatment in Alzheimer's Disease at AD/PD™ 2026

ImmunoBrain a clinicalstage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases today announced that Phase b data for IBCAb a newly engineered proprietary

IXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company

IXCells Biotechnologies USA Inc iXCells a leading provider of human cellbased solutions and custom iPSC services today announced the delivery of over characterized induced pluripotent stem cell

Enhertu granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer

AstraZeneca and Daiichi Sankyos supplemental Biologics License Application sBLA for Enhertu trastuzumab deruxtecan has been accepted and granted Priority Review in the US for the treatment of adult patients

The 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard

When we discuss bacterial infections we often think of exotoxinsthose soluble proteins actively secreted by bacteriawhile overlooking endotoxins which are more insidious but equally dangerous Endotoxins are not released by bacteria rather they are natural components residing in the bacterial